Hospital
Homer Memorial Hospital
Homer Memorial Hospital was paid $5.75M by Medicaid between Jan 2018 and Dec 2024, across 64 billing codes. Its largest line is 99283, emergency room visit (moderate) — 37% of everything it billed.
33Billing provider infoHOMER MEMORIAL HOSPITAL
HOMER, LA 71040
HOMER, LA 71040
33aNPI1831183748assigned 09/07/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.75M
24GClaims63,042
24DCodes billed64
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Louisiana
Rank by total paid#47 of 96
Median peer was paid$5.17M
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,549 | $341K | |
| 2019 | 6,590 | $342K | |
| 2020 | 3,664 | $305K | |
| 2021 | 9,872 | $1.11M | |
| 2022 | 12,657 | $1.39M | |
| 2023 | 14,591 | $1.34M | |
| 2024incomplete | 9,119 | $916K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 37% | 11,296 | 9,304 | $2.14M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 36% | 6,469 | 5,705 | $2.08M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8.8% | 7,469 | 5,138 | $507K |
| 0223U | 4.9% | 756 | 672 | $282K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.6% | 1,402 | 1,318 | $148K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 2,180 | 2,012 | $80K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.3% | 188 | 171 | $76K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 965 | 888 | $73K |
| 80053 | Comprehensive metabolic panel | <1% | 6,569 | 5,834 | $52K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,817 | 6,568 | $48K |
| 71045 | Radiologic examination, chest; single view | <1% | 631 | 570 | $46K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 87 | 76 | $35K |
52 more codes
| 80061 | Lipid panel | <1% | 2,193 | $26K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 374 | $17K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,131 | $17K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 214 | $13K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 517 | $13K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 68 | $12K |
| 84439 | <1% | 1,235 | $10K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,020 | $7K |
| 80050 | General health panel | <1% | 184 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,784 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 206 | $6K |
| G0378 | Hospital observation service, per hour | <1% | 13 | $6K |
| 81001 | <1% | 3,059 | $6K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 39 | $3K |
| 87486 | <1% | 87 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 87 | $3K |
| 87581 | <1% | 87 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 91 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 184 | $3K |
| 80306 | <1% | 167 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 12 | $1K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 96 | $1K |
| 83735 | <1% | 245 | $1K | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | <1% | 92 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 151 | $856.95 |
| 0012A | <1% | 27 | $821.68 | |
| 0011A | <1% | 30 | $709.96 | |
| 81025 | <1% | 90 | $640.20 | |
| 84484 | <1% | 82 | $611.03 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 65 | $605.87 |
| 97597 | <1% | 21 | $473.40 | |
| 94760 | <1% | 87 | $460.62 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 40 | $439.77 |
| 86140 | <1% | 69 | $248.34 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 30 | $233.04 |
| 82607 | <1% | 15 | $226.20 | |
| 82746 | <1% | 15 | $220.50 | |
| 84481 | <1% | 14 | $188.02 | |
| 82553 | <1% | 42 | $184.80 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 17 | $177.38 |
| 82728 | <1% | 13 | $177.19 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 30 | $169.47 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 16 | $166.22 |
| 83655 | <1% | 13 | $157.43 | |
| 80305 | <1% | 15 | $151.20 | |
| 87070 | <1% | 15 | $117.04 | |
| 83550 | <1% | 14 | $113.62 | |
| 83540 | <1% | 15 | $90.58 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 15 | $67.13 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 12 | $23.40 |
| J2704 | Injection, propofol, 10 mg | 0% | 12 | $0.00 |
| 91301 | 0% | 63 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAYNES, TINA (CEO)
| Provider | Location | Paid |
|---|---|---|
| Homer Memorial Hospital | Homer, LA | $1.19M |
| Homer Memorial Hospital | Homer, LA | $36K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.